Back to Search Start Over

Endothelial-Dependent and Independent Vascular Relaxation Effect of Tetrahydropalmatine on Rat Aorta.

Authors :
Zhou ZY
Zhao WR
Shi WT
Xiao Y
Ma ZL
Xue JG
Zhang LQ
Ye Q
Chen XL
Tang JY
Source :
Frontiers in pharmacology [Front Pharmacol] 2019 Apr 16; Vol. 10, pp. 336. Date of Electronic Publication: 2019 Apr 16 (Print Publication: 2019).
Publication Year :
2019

Abstract

Tetrahydropalmatine (THP) is an active natural alkaloid isolated from Corydalis yanhusuo W.T. Wang which has been widely used for treating pain and cardiovascular disease in traditional Chinese medicine. Previous studies suggested THP have various pharmacological effects in neural and cardio tissue while the vascular reactivity of THP was not fully established. The present study found that THP relaxed rat aorta which contracted by phenylephrine (Phe), KCl, and U46619. The vascular relaxation effect of THP was partially attenuated by PI3K inhibitor wortmannin, Akt inhibitor IV, endothelial nitric oxide synthetase (eNOS) inhibitor L-NAME, guanylate cyclase inhibitors and the mechanical removal of endothelium. Also, the eNOS substrate L-arginine reversed the inhibition effect of L-NAME on THP-induced vascular relaxation. THP also induced intracellular NO production in human umbilical vein endothelial cells. However, Pre-incubation with β-adrenergic receptor blocker propranolol, angiotensin II receptor 1 (AT1) inhibitor losartan, angiotensin II receptor 2 (AT1) inhibitor PD123319 or angiotensin converting enzyme inhibitor enalapril enhanced the vascular relaxation effect of THP. THP did not affect the angiotensin II induced vascular contraction. Cyclooxygenase-2 (COX2) inhibitor indomethacin did not affect the vascular relaxation effect of THP. Furthermore, pre-treatment THP attenuated KCl and Phe induced rat aorta contraction in standard Krebs solution. In Ca <superscript>2+</superscript> free Krebs solution, THP inhibited the Ca <superscript>2+</superscript> induced vascular contraction under KCl or Phe stress and reduced KCl stressed Ca <superscript>2+</superscript> influx in rat vascular smooth muscle cells. THP also inhibited intracellular Ca <superscript>2+</superscript> release induced vascular contraction by blocking Ryr or IP3 receptors. In addition, the voltage-dependent K <superscript>+</superscript> channel (Kv) blocker 4-aminopyridine, ATP-sensitive K <superscript>+</superscript> channel (KATP) blocker glibenclamide and inward rectifying K <superscript>+</superscript> channel blocker BaCl <subscript>2</subscript> attenuated THP induced vascular relaxation regardless of the Ca <superscript>2+</superscript> -activated K <superscript>+</superscript> channel (KCa) blocker tetraethylammonium. Thus, we could conclude that THP relaxed rat aorta in an endothelium-dependent and independent manner. The underlying mechanism of THP relaxing rat aorta involved PI3K/Akt/eNOS/NO/cGMP signaling path-way, Ca <superscript>2+</superscript> channels and K <superscript>+</superscript> channels rather than COX2, β-adrenergic receptor and renin-angiotensin system (RAS). These findings indicated that THP might be a potent treatment of diseases with vascular dysfunction like hypertension.

Details

Language :
English
ISSN :
1663-9812
Volume :
10
Database :
MEDLINE
Journal :
Frontiers in pharmacology
Publication Type :
Academic Journal
Accession number :
31057398
Full Text :
https://doi.org/10.3389/fphar.2019.00336